PRKAA2 and polycystic ovary syndrome: The dysregulation of AMPK signalling is increasingly recognised as a contributing factor to a spectrum of female reproductive disorders such as polycystic ovary syndrome (PCOS), endometriosis, infertility, and reproductive ageing, primarily through the disruption of metabolic and inflammatory balance.